Merck & Co. spent $2.6M on lobbying in Q1 2025, focusing on IRA reforms and drug pricing
Why it matters Pharmaceutical giant Merck & Co. deployed $2.6 million on in-house lobbying during 2025’s first quarter, targeting legislation […]
Original reporting on legislation, votes, hearings, lobbying and campaign finance — newest first.
Why it matters Pharmaceutical giant Merck & Co. deployed $2.6 million on in-house lobbying during 2025’s first quarter, targeting legislation […]
Why it matters The auto industry’s main lobbying group is signaling intense policy battles across safety, technology, and environmental regulations […]
Why it matters: Microsoft is continuing its multi million-dollar lobbying operation across several policy issues, with artificial intelligence regulation coming […]
Why it matters As tech regulation intensifies globally, Apple’s latest disclosure reveals strategic priorities that signal legislative and regulatory pressure […]
Why it matters Elevance Health’s operates across commercial, Medicare, and Medicaid markets. Proposed policy changes could affect millions of Americans’ […]
Why it matters The oil giant’s spending signals its strategic prioritization of shaping policies critical to both its traditional operations […]
Why it matters The retail industry’s largest trade association is deploying substantial resources to influence policy on multiple fronts, particularly […]
Why it matters Visa has significantly intensified its lobbying operations, increasing in-house spending by 15% to $2.06 million in Q4 […]
Kaiser Foundation Health Plan dramatically ramped up its lobbying efforts in Q1 2025, spending $3.06 million to influence legislation on […]
Why it matters: Southern Co. is leveraging significant lobbying resources to influence energy policy across nuclear development, environmental regulations, and […]
Why it matters: Defense giant Northrop Grumman significantly ramped up its lobbying efforts in early 2025, spending $3.62 million in […]
Why it matters: The Cigna Group, with its Express Scripts PBM subsidiary, is dedicating significant lobbying resources to influence multiple […]
Rep. Jonathan L. Jackson (D-Illinois) was recently mentioned in a Defense World article published May 15, 2025, which reported his […]
Sen. Mike Rounds (R-S.D.) was recently mentioned in a May 15, 2025 article in The Public Opinion, where he again […]
Senator Peter Welch was recently featured in a May 15 WCAX news article expressing concerns about how tariffs are slowing […]
Rep. Kelly Morrison (D-Minn.) was recently highlighted in a Benzinga Insights article published in May 2025 for purchasing up to […]
Senator Lindsey Graham (R-SC) was recently mentioned in a May 14, 2025 WISTV.com article reporting that Democrat Lee Johnson plans […]
Rep. Blake Moore (R-UT) was featured in a Star Tribune article published May 15, 2025, which reported that he was […]
Rep. John Rutherford (R-FL) questioned Transportation Secretary Sean Duffy about autonomous vehicle development during a House Appropriations Committee hearing, according […]
Sen. John Kennedy (R-La.) voiced concerns about universal injunctions in a Fox News op-ed published through his Senate office, arguing […]
Why it matters Pfizer Inc. has dramatically increased its lobbying expenditures in Q1 2025, investing $4.24 million in-house to influence […]
Amazon’s in-house lobbying operation spent $4.33 million in the first quarter of 2025, slightly less than Q4 2024 but still […]
The big picture: AARP Inc. has significantly ramped up its lobbying efforts in Washington, reporting $6.63 million spent on in-house […]
Why it matters Business Roundtable, the influential CEO association, continues high-level lobbying across a wide range of business priorities, signaling […]